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Popeye domain containing (Popdc) proteins are a unique family, which combine several different
properties and functions in a surprisingly complex fashion. They are expressed in multiple tissues and
cell types, present in several subcellular compartments, interact with different classes of proteins, and
are associated with a variety of physiological and pathophysiological processes. Moreover, Popdc proteins
bind the second messenger cAMP with high afﬁnity and it is thought that they act as a novel class of
cAMP effector proteins. Here, we will review the most important ﬁndings about the Popdc family, which
accumulated since its discovery about 15 years ago. We will be focussing on Popdc protein interaction
and function in striated muscle tissue. However, as a full picture only emerges if all aspects are taken into
account, we will also describe what is currently known about the role of Popdc proteins in epithelial cells
and in various types of cancer, and discuss these ﬁndings with regard to their relevance for cardiac and
skeletal muscle.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. The Popeye domain containing gene family
The ﬁrst member of the Popdc gene family was independently
discovered by two groups through subtractive hybridisation aiming
at the identiﬁcation of novel transcripts with a cardiac muscle-
restricted expression pattern (Andree et al., 2000; Reese et al.,
1999). Reese and colleagues named the novel gene Blood vessel
epicardial substance (Bves), which was based on the expression
pattern they observed by immunolabelling (Reese et al., 1999). Due
to the high expression level in striated muscle tissue, Andree et al.
gave it the name Popeye1 (Pop1), which is a reference to the comic-
strip hero “Popeye the sailor”, who is most famous for his super-
natural muscle strength (Andree et al., 2000). They also discovered
two other related genes expressed in higher vertebrates, and
referred to them as Pop2 and Pop3, in order to indicate their
membership to the same gene family. Today, these genes are known
as the Popeye domain containing (Popdc) genes Popdc1, Popdc2, and
Popdc3 (Brand et al., 2014). In addition, the name Bves is still used as
a synonym for Popdc1.ntre, National Heart and Lung
, Hareﬁeld, UB96JH, United
r Ltd. This is an open access article2. Evolutionary background
Popdc genes are found throughout the animal kingdom and are
already present in Hydra and other Cnidaria indicating that their
roots lie at the base of metazoan evolution (reviewed in Brand et al.,
2014). Signiﬁcantly, at the sequence level Popdc proteins are highly
conserved suggesting that they have an important and essential
role. In vertebrates three Popdc genes are present, while in lower
chordates two genes are found (Brand, 2005). In man, Popdc1 and
Popdc3 are found on human chromosome 6q21 as tandem arrayed
genes, while Popdc2 is localised on human chromosome 3q13.33
(Andree et al., 2000). The tandem array organisation of Popdc1 and
Popdc3 genes is already present in lower chordates, suggesting that
this genomic organisation may have some role at the gene regu-
latory level. However, it is noteworthy in this context that in
addition to gene-speciﬁc transcripts a number of vertebrate species
are predicted to generate also transcripts, which do not obey the
gene boundaries. These transcripts would encode a Popdc3/Popdc1
fusion protein (Andree et al., 2000), however, presently the func-
tional signiﬁcance thereof is unknown. Drosophila is unique in a
having a single Popdc gene, while most invertebrates have two
genes. Some species show a higher level of gene duplication (Brand
et al., 2014). Interestingly, Popdc proteins show some sequence
homology to the bacterial transcription factors Catabolite Activator
Protein (CAP) and cAMP Receptor Protein (CRP), which are involvedunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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karyotic transcription factors and the transmembrane Popdc pro-
teins, which are found in metazoans have a common evolutionary
origin (Schindler et al., 2012; Simrick et al., 2013).
3. Expression pattern of Popdc proteins
All three members of the Popdc gene family are expressed in
cardiac and skeletal muscle (Andree et al., 2000; Breher et al.,
2004). In the heart, Popdc1 expression in the embryonic heart is
equally strong in both atrial and ventricular chambers, whereas
postnatally, Popdc1 expression is weaker in ventricular compared
to atrial myocardium. Popdc2 on the other hand is expressed at
equal levels in both chamber types. The highest expression level for
Popdc1 and Popdc2 is observed in the cardiac conduction system
including the sinoatrial (SAN) and atrioventricular nodes (AVN)
(Froese et al., 2012).
There still exists some controversy with regard to the cell types
in the heart that express Popdc1. The ﬁrst report of the cardiac
Popdc1 expression pattern at the protein level by David Bader and
colleagues described an expression in the epicardium and the
coronary vasculature (Reese et al., 1999). However, b-galactosidase
(LacZ) staining of tissues from a Popdc1-LacZ knockin mouse,
revealed expression in cardiac myocytes and absence of staining in
the epicardium, coronary arteries and other nonmuscle cell types
(Andree et al., 2002a). Moreover, immunohistochemistry, in situ
hybridisation, and RT-PCR analysis of the chick andmouse heart did
not reveal any expression in the proepicardium, epicardium or
coronary vasculature (Andree et al., 2002a, 2002b; Torlopp et al.,
2006).
It is noteworthy that in addition to the abundant expression in
striated muscle tissue, Popdc1 is also present in smooth muscle
cells of bladder, uterus, and the gastrointestinal tract, as well as in
the brain, various epithelia, spinal ganglia, thymus, testes, stomach,
lungs, kidneys, and spleen (Andree et al., 2000; Hager and Bader,
2009; Osler and Bader, 2004; Osler et al., 2006; Reese et al., 1999;
Ripley et al., 2004; Smith and Bader, 2006; Torlopp et al., 2006;
Vasavada et al., 2004). The expression pattern of Popdc2 has also
been analysed and display strong overlap with Popdc1, however
some differences have also been observed (Froese and Brand, 2008;
Froese et al., 2012). Due to a lack of immunoreagents and appro-
priate mouse models, Popdc3 expression has not yet been exten-
sively studied. However, preliminary data revealed an expression
pattern similar to Popdc1 (Andree et al., 2000). Immunoﬂuorescent
analysis of the subcellular localisation of Popdc1 and Popdc2 pro-
teins in cardiac myocytes established a strong labelling of the
plasma membrane, with all three membrane compartments being
labelled, i.e. the intercalated disk, the lateral membrane and the t-
tubules (Froese et al., 2012).
4. Structure and biochemical properties of Popdc proteins
Popdc proteins are three-pass transmembrane proteins with a
short extracellular amino-terminus, which contains up to two N-
glycosylation sites (Andree et al., 2000; Knight et al., 2003).
Glycosylation is quite extensive in these proteins and signiﬁcantly
affecting the electrophoretic mobility in SDS-PAGE. Popdc1 for
example runs at 58 kDa, while the protein sequence predicts a
molecular weight of about 42 kDa. Interestingly, the extent of
glycosylation and therefore electrophoretic mobility is tissue-
dependent (Vasavada et al., 2004). Thus, POPDC1 protein isolated
from chicken heart and skeletal muscle runs at 58 and 70 kDa,
respectively. Possibly the size differences are based on tissue-
speciﬁc regulation of glycosylation. The impact of glycosylation
on Popdc function is presently unknown, however, it has beenhypothesised that it may play a role in membrane localisation of
Popdc proteins or protect them from proteolytic decay (Hager and
Bader, 2009). Importantly, Popdc proteins form homodimers,
which are stabilised by disulﬁde bonds and may be necessary for
the maintenance of epithelial integrity and junctional stability
(Hager and Bader, 2009). How homodimerisation is mediated is
presently unclear. Although it has been previously reported that
conserved lysines at the carboxy-terminal end of the Popeye
domain of Popdc1 mediate homodimerisation (Kawaguchi et al.,
2008), it was subsequently shown that Popdc1 protein lacking
this sequence motif is still able to homodimerise, suggesting that
there are probably also other protein domains involved, which have
not yet been identiﬁed (Russ et al., 2011). The C-terminus of Popdc
proteins is located in the cytoplasm and contains the Popeye
domain (PFAM: PF04831), which consists of about 150 amino acids
and shows high sequence conservation (Andree et al., 2000). The
Popeye domain harbours a functional cyclic nucleotide binding
domain (CNBD), which enables Popdc proteins to speciﬁcally bind
to and be modulated by adenosine 30,50-cyclic monophosphate
(cAMP). Popdc proteins probably do not bind guanosine 30,50-cyclic
monophosphate (cGMP), since the afﬁnities for both cyclic nucle-
otides differ by a factor of about 40 (Froese et al., 2012). Thus, Popdc
proteins are one of only ﬁve classes of eukaryotic cAMP effector
proteins, which, apart from protein kinase A (PKA), include ex-
change protein directly activated by cAMP (Epac), and
hyperpolarisation-activated cyclic nucleotide-gated cation (HCN)
channels (Rehmann et al., 2007). Recently, a sperm-speciﬁc novel
cyclic nucleotide receptor (CRIS) has been reported (Krahling et al.,
2013). Although the Popeye domain is predicted to be structurally
similar to other cAMP binding domains, at the sequence level only
very limited similarity is present. The actual phosphate binding
cassette (PBC), which makes contact to the cyclic nucleotide is very
different and does not resemble the PBC found in the other cAMP
effector proteins (Brand et al., 2014). Using a radioligand binding
assay and by FRET analysis, Froese and colleagues have demon-
strated that the cAMP afﬁnity of Popdc proteins is about 10-fold
higher than that of Epac1 and similar to that of PKA (Froese et al.,
2012). Charge-to-alanine mutations of an invariant aspartate res-
idue (D200 in Popdc1 and D184 in Popdc2), which is part of the
ultra-conserved DSPE sequence motif present in most POPDC
proteins and thought to be part of the CNBD, eradicated cAMP
binding, suggesting that this residue is crucial for cyclic nucleotide
binding (Froese et al., 2012). Carboxy-terminal to the Popeye
domain is a sequence, which is variable in length amongst Popdc
family members. In Popdc1 this carboxy-terminal sequence is rich
in acidic amino acids and contains an array of serine/threonine
residues, which are subject to phosphorylation after b-adrenergic
stimulation (Lundby et al., 2013).
5. Functional impact of the Popeye domain containing
protein family
5.1. Popdc1 is involved in cellecell contact formation and regulates
epithelial function
Popdc1 has been shown to be an essential component of tight
junctions and to be important for proper epithelial function. In
mature epithelia including murine small intestine epithelium,
Popdc1 was found to co-localise with constituents of the tight
junction complex such as occludin, and a direct interaction of
Popdc1 and ZO-1 has been established by GST pull-down (Osler
et al., 2005). It has been hypothesised that via this proteinepro-
tein interaction Popdc1 plays an important role in the formation
and maintenance of epithelial monolayers. In human corneal
epithelial cells, Popdc1, presumably through interaction with ZO-1,
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junctions thereby regulating the junctional localisation of these
proteins and their downstream signalling (Russ et al., 2011). Also in
trabecular meshwork cells, Popdc1 inhibits RhoA signalling, lead-
ing to a decreased phosphorylation of myosin light chain, a
downstream target of the RhoA-ROCK signalling pathway (Russ
et al., 2010). It is thought that Popdc1 regulates trabecular mesh-
work cell contraction and thereby aqueous outﬂow and intraocular
pressure in the eye. Furthermore, overexpression of Popdc1 causes
an increase in tight junction formation and transepithelial resis-
tance (Russ et al., 2010, 2011). While RhoA-ROCK signalling in the
heart has been associated with several functions, including cardiac
conduction and repolarization (Sugiyama et al., 2003), it is pres-
ently unknown whether Popdc proteins are modulating this
pathway in the heart as well. In zebraﬁsh an interaction of Popdc1
with atypical protein kinase C (aPKC) has recently been reported
(Wu et al., 2012) and aPKC controls tight junctional integrity by
recruiting and tethering components of the tight junction signal-
ling complex. In addition to tight junctions, Popdc1 also regulates
adherens junction formation in epithelial cells. In human corneal
epithelial cells as well as colorectal cancer cells, E-cadherin
expression and b-catenin localisation correlate with the level of
Popdc1 expression (Williams et al., 2011). Bymodulating both, tight
junctions and adherens junctions, Popdc1 has been implicated in
the control of epithelialemesenchymal transition (EMT) (Williams
et al., 2011; Han et al., 2014). The important role of Popdc1 in
cellecell contact formation has also been established in the context
of eye development (Ripley et al., 2004; Wu et al., 2014). Interest-
ingly, Popdc1 is rapidly recruited to cellecell contact sites, and
forced expression of Popdc1 in non-adherent L-cells increased
adhesiveness (Wada et al., 2001). It was proposed that Popdc1
might act as a cell adhesion molecule. However, the extracellular
domain of the Popdc proteins is only 20e40 residues long, it is
therefore unlikely that Popdc proteins are directly involved in
establishing cellecell adhesion. However, it is possible, that adhe-
sion is mediated indirectly through interacting proteins, or that the
extensive glycosylation of Popdc proteins is of importance in this
context.
During early Drosophila embryogenesis, the epithelial function
of Popdc1 seems to be important. Knockdown of Popdc1 (DmBves)
in Drosophila causes impaired pole cell migration and abnormal
gastrulation (Lin et al., 2007). Likewise, in Xenopus, Popdc1 mor-
pholino injection caused a developmental arrest at gastrulation
(Ripley et al., 2006). However in contrast to these reports, zebraﬁsh
popdc1 or popdc2 morphants revealed no gastrulation phenotype
(Kirchmaier et al. 2012; Schindler et al., 2016). Moreover, the lack of
an embryonic phenotype in the Popdc1 or Popdc2 null mutant in
mice do not support an essential function of Popdc genes during
early development (Andree et al., 2002b; Froese et al., 2012).
However, it cannot be ruled out that Popdc genes show some
species-speciﬁc functional differences.
Although Popdc function in contact structures has not yet been
studied in cardiac tissue, it is reasonable to assume that this protein
family is also involved in the regulation of intercellular junctions in
the heart. The intercalated disks (ICD) are the contact structures
that mediate mechanical and electrical coupling between myo-
cytes. They consist of adherens junctions, desmosomes, and gap
junctions (Palatinus et al., 2011). An important constituent of the
ICD is the Popdc1-associated protein ZO-1 (Osler et al., 2005). ZO-1
interacts with the main components of both adherens junctions
such as N-cadherin and gap junctions such as Connexin43 aswell as
with the actin cytoskeleton, and is important for the structural
organisation of intercalated disks (Palatinus et al., 2011). Given the
fundamental role of intercalated discs for the function of car-
diomyocytes, as well as pathologies associated with dysfunctions ofintercalated disk constituents, the role of Popdc proteins in this
context deserves further studies.
In addition to modulating cellecell adhesion Popdc1 also reg-
ulates epithelial morphogenesis and cell movements in epithelia.
With the help of a yeast two-hybrid screen and GST pull-down,
GEFT has been established as an interaction partner of Popdc1
(Smith et al., 2008). A domain, which seems to be necessary but not
sufﬁcient to mediate interaction has been mapped to an intracel-
lular portion between aa 250 and aa 300 that partially overlaps
with the Popeye domain of Popdc1 (Smith et al., 2008). GEFT, an N-
terminally truncated isoform of p63RhoGEF, is a guanine nucleotide
exchange factor (GEF) for Rho-family GTPases Rac1 and Cdc42,
activating these small G proteins by catalysing the exchange of GDP
to GTP. GEFT is highly expressed in brain, heart and skeletal muscle.
Overexpression of GEFT leads to a re-organisation of the actin
cytoskeleton and alteration in cell morphology and cell migration.
GEFT overexpression also promotes cell proliferation and may
therefore have a role in tumourigenesis (Guo et al., 2003; Lutz et al.,
2004). Transfection of a truncated Popdc1 construct lacking the
transmembrane domains into NIH3T3 cells resulted in a reduced
activation of Rac1 and Cdc42, but not of RhoA. Furthermore, cells
transfected with Popdc1 showed a more prominent roundness and
exhibited a reduced speed of cell locomotion compared to controls
without alteration of directionality of cell movement. Interestingly,
GEFT overexpression in C2C12 cells induced differentiation (Bryan
et al., 2005), whereas the transfection of a carboxy-terminal
Popdc1 construct resulted in reduced differentiation of
C2C12 cells (Smith et al., 2008). However, it has not been shown
that this observation was a direct result of altered GEFT and Rac1/
Cdc42 activity induced by the carboxy-terminus of Popdc1. There-
fore, the impact of Popdc1-GEFT function in muscle cells remains
unknown. Furthermore, it is presently unclear by which mecha-
nism Popdc1 modulates GEFT. Direct control of GEFT and its
nucleotide binding ability, sequestering of GEFT and therefore
preventing it from activating its downstream effectors, as well as
regulating proper subcellular localisation of GEFT have been pro-
posed as potential mechanisms (Hager and Bader, 2009; Smith
et al., 2008). Although there is no experimental proof as yet, it is
plausible to assume that Popdc1 interacts with the p63RhoGEF
protein. In the heart, p63RhoGEF protein is predominantly
expressed in non-myocytes, however, it is also present at the I-band
of the sarcomere in cardiomyocytes (Souchet et al., 2002; Wuertz
et al., 2010). In this context it is noteworthy that Popdc proteins
have been associated with structural abnormalities in the sinus
node of Popdc1 and Popdc2 null mutant mice (Froese et al., 2012).
5.2. Popdc1 controls vesicular transport and fusion
Using CoIP and GST pull-down experiments Popdc1 has been
established as a interacting partner of the vesicle-associated
membrane proteins Vamp2 and Vamp3 (Hager et al., 2010).
Vamp3, also known as cellubrevin, is a ubiquitously expressed ve-
sicular SNARE protein that plays a role in vesicle fusion and in
trafﬁcking of several membrane proteins such as transferrin or b-
integrin, and thereby regulates cell motility (Galli et al., 1994;
Luftman et al., 2009; McMahon et al., 1993; Proux-Gillardeaux
et al., 2005; Tayeb et al., 2005). Interestingly, overexpression of a
dominant-negative form of Popdc1 in MDCK cells, containing only
the ﬁrst 118 amino acids of the protein (Bves118), resulted in
decreased transferrin uptake and b1-integrin internalisation as
well as in impaired exocytosis. Similar effects were also seen in
Xenopus embryos by antisense morpholino-mediated depletion of
either Popdc1 or Vamp3. As a consequence, cell spreading, a process,
which depends on integrin recycling, was impaired in these
models. Furthermore, Popdc1 knockdown led to morphological
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therefore been concluded that Popdc1, via interaction with Vamp3,
controls important cellular and physiological processes where ve-
sicular transport is required. Intriguingly, in the heart, Vamp2 is
involved in secretion of atrial natriuretic peptide (ANP) from atrial
myocytes (Ferlito et al., 2010). Interestingly, also the Popdc protein
interaction partner TREK-1 (see below) has been associated with
ANP release (McGrath and de Bold, 2009).
A role for Popdc1 in vesicular trafﬁcking is also supported by the
fact that Popdc1 interacts with the N-myc Downstream Regulated
Gene 4 (NDRG4) and thereby controls the fusion of Vamp3-positive
recycling endosomes with the cell surface membrane. If this
interaction was disrupted, directional movement of epicardial cells
was randomised and accelerated due to interfering with the auto-
crine ECM deposition pathway, by which internalised ﬁbronectin is
recycled and eventually re-secreted (Benesh et al., 2013). It is
noteworthy that the binding site for NDRG4 has been mapped to a
region between amino acids 307 and 316 of the Popdc1 protein,
which is outside of the Popeye domain and not shared by either
Popdc2 or Popdc3 suggesting that probably only Popdc1 is able to
interact with NDRG4 (Benesh et al., 2013).
5.3. Popdc genes and cancer
Several studies have demonstrated that POPDC1 and -3
expression is down-regulated in various types of cancer. This
ﬁnding is consistent with the impact of POPDC1 on cell motility and
cell adhesion, and its role in junctional structures and EMT, a
hallmark of cancer and key process for invasiveness of tumours
(Micalizzi et al., 2010). Even though at the ﬁrst glance these ﬁndings
may appear to be irrelevant for the heart, it is likely that there are
overlapping functions of Popdc proteins in different tissue types.
Moreover, some of the principal disease-causing mechanisms may
be similar.
The POPDC1 promoter in tumour tissue from non-small cell lung
cancer patients is signiﬁcantly more frequently and at higher levels
methylated in comparison to matched normal tissue resulting in
reduced expression of POPDC1 in the cancerous tissue (Feng et al.,
2008). Hypermethylation of the POPDC1 promoter was not detec-
ted in cancer-free lung tissue, including pre-cancerous lungs of
tobacco smokers, suggesting a role of POPDC1 at advanced cancer
stages (Feng et al., 2008; Salskov et al., 2011). Similarly, down-
regulation of POPDC1 and -3, but not of POPDC2, has been
revealed in many gastric cancer cell lines and in gastric tumour
samples. Again, gene silencing by promoter hypermethylation as
well as histone deacetylationwas observed. In addition to promoter
hypermethylation, also EGF treatment, which is known to promote
cell migration and invasion by positive regulation of Rac1 and
Cdc42, resulted in an immediate decrease of POPDC1 and -3
expression probably through repression by SnaiI, which is up-
regulated after EGF stimulation (Kim et al., 2010a; Lee et al.,
2008). Likewise, in hepatocellular cancer cell lines and tumour
samples POPDC1was found to be down-regulated (Han et al., 2014).
Moreover, reduced POPDC1 expression was shown to increase the
expression of mesenchymal markers such as vimentin, and to
reduce epithelial proteins like E-cadherin, which was accompanied
by a signiﬁcant increase of the EMT-promoting transcription factors
Snail1 and Twist1. Interestingly, in Drosophila the EGF homologue
gurken suppresses Popdc1/DmBves expression in the dorsal follic-
ular epithelium of the egg chamber (Lin et al., 2007). Similarly,
down-regulation of Popdc1 and -3 but not of Popdc2 expression by
EGF has been observed in rat neonatal cardiac myocytes (Parnes
et al., 2007). It has been shown that loss of POPDC3 in gastric
cancer leads to enhanced cell migration and invasion. This is
accompanied by a reduction of ZO-1 and occludin expression. It hastherefore been proposed that down-regulation of POPDC1 and -3
contributes to a loss of cellecell contacts as well as to enhanced cell
motility by up-regulation of Rac1 and Cdc42, resulting in increased
cell migration and invasion (Kim et al., 2010a). Furthermore, it was
demonstrated that POPDC1 expression is down-regulated via AKT
activation by netrin-1 in hepatocellular carcinoma (Han et al.,
2015). It can therefore be concluded that POPDC1 expression is
regulated by several different signalling pathways. In addition, the
regulation of GEFT, Vamp3, and NDRG4 by Popdc1 and its modu-
latory effects on cell shape and motility as well as on vesicle traf-
ﬁcking including integrin-dependent cell movements may
mechanistically be involved in cancer progression (Benesh et al.,
2013; Hager et al., 2010; Kim et al., 2010b). It is noteworthy that
both, POPDC1 and POPDC3 showed a predominant cytoplasmic
localisation in tumours. Thus, in addition to differences in expres-
sion levels, altered subcellular localisation is also supposed to play a
role in gastric cancer (Luo et al., 2012). In addition to gastric and
lung cancer, abnormal POPDC1 and -3 expression and its impact on
tumourigenesis has been described for colorectal cancer (Williams
et al., 2011) and uveal melanoma (Jayagopal et al., 2011).
5.4. Popdc proteins interact with ion channels
Due to the prominent expression of Popdc proteins at the
plasma membrane it was hypothesised that Popdc proteins may
modulate electrogenic proteins in cardiomyocytes. To test this hy-
pothesis a screen was performed using Xenopus oocytes to analyse
conductivity changes of ion channels in the presence of Popdc
proteins. This led to the identiﬁcation of the potassium channel
TWIK-related Kþ channel 1 (TREK-1) as novel Popdc interacting
protein (PIP) and as the ﬁrst protein interaction partner of Popdc2
and -3 (Froese et al., 2012). TREK-1 is a mechano-sensitive member
of the two-pore domain potassium channel (K2P) family, which
consists of 6 subfamilies: TWIK, TREK, TASK, TALK, THIK, and TRESK
channels (Enyedi and Czirjak, 2010). K2P channels form dimers
consisting of two subunits with each showing the arrangement of
two pore-forming units that are ﬂanked by two transmembrane
helices. TREK-1 is a highly regulated protein that is sensitive to
various stimuli including membrane stretch, intracellular pH,
temperature, phosphorylation, and proteineprotein interactions
(reviewed in Honore, 2007). The main region by which these reg-
ulatory mechanisms are mediated is the so-called post-M4 regu-
latory region located in the C-terminal part of the protein just next
to the fourth transmembrane domain. The post-M4 regulatory re-
gion also harbours a binding site for A kinase anchoring protein 150
(AKAP150). Binding of AKAP150 changes the conductivity of TREK-
1 and modulates inhibition of the channel via Gs and Gq-coupled
receptor signalling, with an acceleration of the Gs transduced in-
hibition and an increase of inhibition via Gq-coupled receptors
(Sandoz et al., 2006). Moreover, TREK-1 is also regulated by the
interaction with microtubule-associated protein 2 (Mtap2), which
is involved in microtubule-dependent transport of the channel to
the plasma membrane. Mtap2 and AKAP150 can bind to TREK-1
simultaneously and modulate the channel synergistically (Sandoz
et al., 2008). Another interaction partner, which promotes surface
localisation and whole-cell currents of TREK-1, is b-COP. This pro-
tein is part of the COPI complex and involved in vesicular transport.
Interestingly, b-COP protein interaction is not mediated by the C-
terminus of TREK-1 but by its N-terminus (Kim et al., 2010b).
Intriguingly, co-expression of both Popdc1 (or Popdc2 or -3) and
TREK-1 in the Xenopus oocyte system results in a current, which is
about 2-fold higher than the current when TREK-1 is expressed
alone. This involves direct physical interaction of TREK-1 and the C-
terminus of Popdc proteins as demonstrated for Popdc1 by a GST
pull-down (Froese et al., 2012). Similar to other CNBDs (Rehmann
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mational change upon cAMP binding. Likewise a bi-molecular
sensor consisting of Popdc1-CFP and YFP-TREK-1 demonstrated
direct physical interaction. Moreover, the FRET ratio obtained under
baseline condition decreased after raising the intracellular cAMP
levels with isoproterenol or forskolin, indicating a structural rear-
rangement of the sensor proteins to one another caused by a
conformational change in the Popeye domain (Froese et al., 2012).
This conformational change could possibly have several effects on
Popdc proteins and their interaction partners (Fig. 1). It can be
imagined that the conformational change induced by cAMP binding
results in the exposure of a binding site on Popdc proteins, which is
not accessible under baseline conditions. Conversely, other binding
sites may only be accessible when no cAMP is bound and cAMP
binding would result in a release of the PIP, which may then
become accessible for other proteins including modulating en-
zymes, proteases, etc. Furthermore, it is possible that the confor-
mational change in Popdc proteins may not alter the interaction
with the PIP itself but may induce conformational rearrangements
in directly interacting proteins, and thus enabling or disabling the
binding of the PIP to a third protein. Therefore, cAMP binding may
have effects not only on proteins directly interacting with Popdc
protein but also those, which are only indirectly associated with
them. In addition to the modulation of proteineprotein in-
teractions, cAMP binding to Popdc proteins could also have an
impact on the activity of other cAMP effector proteins by regulating
local cAMP concentrations. The functional consequences of these
mechanisms have previously been described in the “cargo model”
and the “switch model” (Brand et al., 2014). The cargo model de-
scribes that cAMP binding to Popdc proteins could enhance surface
expression of associated proteins either by docking to an anchor
protein in the cell surface membrane or bymodulating intracellular
trafﬁcking. The switch model postulates that Popdc proteins might
directly affect the function of interacting proteins, e.g. the con-
ductivity in the case of an ion channel such as TREK-1 (Froese et al.,
2012). Moreover, additional functions could be proposed such as
preventing proteins from proteolytic decay or fromFig. 1. Potential mechanisms by which cAMP binding may modulate Popdc proteins a
Popeye domain (red), which may result in the exposure of a binding site for PIPs that do no
only be able to bind to Popdc proteins under baseline conditions and may be released upon
interact with other proteins (b). It could also be assumed that conformational changes in the
change in it, thereby enabling or disabling it to bind to and regulate other proteins, whic
proteineprotein interactions exist, which are not affected by cAMP binding (d). Importantly,
Popdc proteins but could also involve the transmembrane domains and the extracellular pphosphorylation or from other types of posttranslational modiﬁ-
cation, etc. as recently proposed in the shielding model (Schindler
et al., 2016).
Importantly, the increase in TREK-1 conductivity is accompa-
nied by an about 2-fold higher membrane localisation of TREK-1,
suggesting that Popdc proteins modulate membrane trafﬁcking of
TREK-1 (Froese et al., 2012). However, it is presently unclear how
this is achieved and whether Mtap2 or b-COP are involved. Inter-
estingly, this modulation seems to be speciﬁc for TREK-1 as the
closely related TASK-1 channel was not affected by co-expression
with Popdc1 (Froese et al., 2012). Even though the physiological
impact of Popdc-TREK-1 interaction is still unclear, it is believed
that Popdc proteins modulate the resting membrane potential and
thereby the excitability of cardiac myocytes (Boukens and
Christoffels, 2012; Froese et al., 2012). In epithelia and cancer
cells, Popdc1 has been shown to modulate fundamental cellular
processes like vesicular trafﬁcking, which may have a profound
impact also for membrane localisation of ion channels, trans-
porters, and pumps. Also the complexity of phenotypes in animal
models lacking Popdc proteins points to the involvement of other
mechanism and interactions, by which Popdc proteins modulate
cardiac excitability under baseline condition and under stress. In
this context it is also noteworthy that the mechano-sensitive TREK-
1 protein may provide a substrate for Popdc-mediated regulation of
mechanical properties in cardiac myocytes and neurons and
thereby regulate stretch-related processes like the secretion of
atrial natriuretic peptide (ANP) (McGrath and de Bold, 2009). Thus,
Popdc proteins may be involved in mechanical and electrical
coupling. In favour for this hypothesis is also themultiple direct and
indirect involvement of the cytoskeleton. Popdc1 has been shown
to regulate the organisation of actin ﬁlaments via interaction with
GEFT (Smith et al., 2008). Importantly, also TREK-1 is involved in
cytoskeletal arrangement (Lauritzen et al., 2005). Moreover, the
actin-associated protein ßIV-spectrin regulates TREK-1 membrane
targeting (Hund et al., 2014) and so do Popdc proteins (Froese et al.,
2012). Therefore, a complex regulatory network involving cyto-
skeletal components, mechanosensors, and Popdc proteins exist,nd PIPs. It is supposed that binding of cAMP leads to a conformational change in the
t interact with Popdc proteins when cAMP is not bound (a). In contrast, other PIPs may
cAMP binding to the Popeye domain. In turn, these proteins may then be accessible to
Popeye domain do not directly affect binding of a PIP but may induce a conformational
h are only indirectly associated with Popdc proteins (c). In addition, it is likely that
proteineprotein interactions are not necessarily conﬁned to the cytoplasmic portion of
arts (#). Also these interactions may be affected by cAMP binding.
R.F.R. Schindler, T. Brand / Progress in Biophysics and Molecular Biology 120 (2016) 28e36 33which deserves further scientiﬁc attention.
5.5. Popdc1 interacts with Caveolin-3 and controls number and size
of caveolae
A novel PIP in the heart is the caveolae protein Caveolin-3
(Alcalay et al., 2013). Caveolae are ﬂask-shaped membrane in-
vaginations and play important roles in different physiological
processes including vesicular trafﬁcking and signal transduction
(reviewed in Gazzerro et al., 2010). It is supposed that Popdc1
regulates number and size of caveolae as in Popdc1 null mutant
mice fewer caveolae were present, which were larger in size
compared to wildtype controls. Moreover, alteration in Ca2þ tran-
sients and increased vulnerability of the null mutant heart to
ischemia-reperfusion injury have been observed (Alcalay et al.,
2013). Importantly, the binding site of Popdc1 for Caveolin-3 has
been mapped to a motif located in the Popeye domain, which is
predicted to form the lid structure of the CNBD (Alcalay et al., 2013),
which is supposed to undergo profound conformational changes
after cAMP binding (Rehmann et al., 2007). It may therefore be
possible that conformational changes in the Popeye domain have a
strong effect on the Caveolin-3/Popdc1 complex and other associ-
ated proteins. Interestingly, the protein composition of caveolae is
dynamic and regulated by beta-adrenergic stimulation
(Wypijewski et al., 2015). It may be possible that Popdc proteins are
involved in this by mechanisms described in Fig. 1. Moreover,
depletion of Popdc proteins may result in uncoordinated caveolar
organisation, whichmay contribute to the abnormal stress-induced
arrhythmia and the vulnerability to ischemia-reperfusion injury.
However, thorough investigation under baseline conditions and
after b-adrenergic stimulation will be necessary to better under-
stand the role of Popdc proteins in regulation of caveolar number,
size, and function. Interestingly, caveolae have been implicated in
mechano-sensing and mechano-transduction (reviewed in
Calaghan, 2011), and via interaction with Caveolin-3, Popdc1 may
contribute to that functions. However, one must not forget that
interaction is unlikely to be a unidirectional process with Popdc1
regulating Caveolin-3. In fact, Caveolin-3 may also modulate
Popdc1, e.g. with regard to its subcellular localisation and potential
clustering with other proteins involved in b-adrenergic
signalling processes (Xiang, 2011).
5.6. Popdc proteins are important players in cardiac and skeletal
muscle physiology
Popdc proteins are most abundantly present in striated muscle
tissue and indeed, genetic inactivation of Popdc1 and -2 in mouse
models demonstrated their important physiological roles in these
tissues (Andree et al., 2002a; Froese et al., 2012). In the heart, loss of
either Popdc1 or Popdc2 resulted in severe arrhythmia phenotypes
with the presence of sinus pauses (temporary loss of sinus node
activity) leading to a strong reduction in mean heart rate and
therefore to a bradycardia phenotype with a high heart rate vari-
ability (Table 1) (Froese et al., 2012). Importantly, this bradycardia
did not occur at rest but was provoked by either physical (swim-
ming) or mental (hot air jet) stress. Moreover, also isoproterenol
treatment led to the stress-induced bradycardia phenotype in the
null mutants, similar to what was seen after physical or mental
stress. In contrast, carbachol treatment resulted in a comparable
drop in heart rate in both genotypes, suggesting that para-
sympathetic stimulation is not altered in the null mutants (Froese
et al., 2012). Importantly, in both Popdc1 and Popdc2 null mu-
tants, the bradycardia develops in an age-dependent manner,
which means that young animals (3 months old) do not have the
phenotype but the older the animals grow the more severe thephenotype becomes (Froese et al., 2012). Due to the similarities of
the phenotypes observed in animal models Popdc genes have
tentatively been associated with the sick sinus syndrome (SSS) in
human patients. The bradycardia is independent of the autonomic
nervous system as it also present in isolated null mutant hearts.
Interestingly, in these mouse models no functional alterations of
the atrioventricular (AV) node were seen (Froese et al., 2012).
However, in Popdc1/Popdc2 double null mutants, AV block has been
observed (Simrick et al., 2012). Electrical activity in the working
myocardium seems to be unaffected in younger Popdc single null
mutant mice (Froese et al., 2012), however, in Popdc1/Popdc2 dou-
ble null mutants functional impairments of the working myocar-
dium with atrial ﬁbrillation, polymorphic ventricular tachycardia,
and extrasystoles has been observed in addition to sinus pauses. In
isolated ventricular myocytes, b-adrenergic stimulation caused
delayed-after-depolarisations (DADs), spontaneously generated
action potentials, and shortening of action potential durations
(Simrick et al., 2012, 2013). It has been described that in older (8
months) Popdc1/ and Popdc2/ mice the dysfunction on the
electrophysiological level is accompanied by degeneration of the
sinoatrial node, particularly in the inferior part, which is important
for pacemaking after adrenergic stimulation, and by structural
abnormalities such as a reduction of cellular extensions (Froese
et al., 2012; Opthof, 1988). The molecular basis for these changes
has yet to be determined. It may be possible that mechanisms
similar to what was described for epithelial cells may also play a
role in this context such as the effect of interaction with GEFT or
Vamp3 etc (see above), however, experimental evidence has not yet
been obtained. Also the relative contribution of the electrophysio-
logical and the structural abnormalities is not fully understood and
requires further studies. Furthermore, abnormal Ca2þ transients are
present in Popdc1 null mutants, and an increase vulnerability to
ischemia-reperfusion injury has been documented (Alcalay et al.,
2013).
In zebraﬁsh morphants depletion of popdc2 and popdc1 leads to
electrophysiological phenotypes such as cardiac conduction defects
causing 2:1 and 3:1 atrioventricular (AV)-block (Table 1)
(Kirchmaier et al., 2012; Schindler et al., 2016). The morphants
showed high variability in atrial and ventricular heart rate and
irregular action potential durations. If higher morpholino concen-
trations were used, morphological changes were seen including
looping defects, and abnormal heart chambers characterised by
reduced myoﬁbrillar content and a lack of trabeculation. Moreover,
large pericardial oedemas were often seen, which is indicative for
embryonic heart failure (Kirchmaier et al., 2012).
5.7. A mutation in POPDC1 causes cardiac arrhythmia and
muscular dystrophy by affecting protein trafﬁcking
Recently, a family suffering from AV-block and limb-girdle
muscular dystrophy was identiﬁed, which carries a recessive
serine 201 to phenylalanine (S201F) point mutation (Schindler
et al., 2016). This S201 residue is ultra-conserved and invariable
present in all Popeye domains. It is part of the DSPEmotif in the PBC
which directly interacts with cAMP (Froese et al., 2012). Measuring
cAMP binding revealed a signiﬁcant loss in binding afﬁnity of the
mutant POPDC1S201F protein. Co-expression of the of the mutant
POPDC1S201F protein together with TREK-1 in Xenopus oocytes
revealed an augmented TREK-1 current, which was not altered in
response to raising cAMP levels (Schindler et al., 2016). Despite the
increased membrane current, TREK-1 protein showed a reduction
in membrane localisation, suggesting impaired membrane traf-
ﬁcking. Skeletal muscle biopsies of family members carrying the
S201F mutation displayed an aberrant plasma membrane local-
isation of POPDC1, which was signiﬁcantly reduced, while the
Table 1
Cardiac and skeletal muscle functions of Popdc proteins.
Function Reference
Popdc1, Popdc2, and Popdc3 are predominantly expressed in heart and skeletal muscle (Andree et al., 2000)
POPDC1 and POPDC3 are down-regulated in human heart failure (Gingold-Belfer et al., 2011)
POPDC1 expression is upregulated in patients with ventricular septal defects (Zhang et al., 2006)
Popdc1 is associated with atrial ﬁbrillation (Tan et al., 2013)
Popdc1 has been implicated in the development of Tetralogy of Fallot (Wu et al., 2013)
Popdc1 interacts with Caveolin-3 and Popdc1/ mice display a reduction in number and an increase in the size of caveolae (Alcalay et al., 2013)
Loss of Popdc1 results in increased vulnerability to ischemia-reperfusion injury (Alcalay et al., 2013)
Popdc1, Popdc2, and Popdc3 interact with the K2P channel TREK-1 (Froese et al., 2012)
Popdc1 controls membrane trafﬁcking of TREK-1 (Froese et al., 2012)
Depletion of either Popdc1 or Popdc2 results in an age-dependent stress-induced bradycardia phenotype in mice (Froese et al., 2012)
Depletion of popdc2 results in AV-block and muscular dystrophy in zebraﬁsh morphants (Kirchmaier et al., 2012)
Depletion of either Popdc1 or Popdc2 in mice results in structural remodelling of SAN tissue (Froese et al., 2012)
The point mutation POPDC1S191F causes cardiac arrhythmia and muscular dystrophy in patients (Schindler et al., 2016)
Popdc1 and Popdc2 interacts with Dystrophin, Dysferlin, (Schindler et al., 2016)
Popdc1 controls the formation of the myotendinous junction (Schindler et al., 2016)
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Aberrant membrane trafﬁcking was not conﬁned to the mutant
POPDC1 protein but was also observed for POPDC2 (Schindler et al.,
2016). A S191F mutation was introduced into the popdc1 gene in
zebraﬁsh and the resulting homozygous mutant also displayed
muscular dystrophy and cardiac arrhythmia, and therefore resem-
bled the mutant phenotype in patients carrying the homologous
S201F mutation in homozygosity. Moreover, also the zebraﬁsh
popdc1S191F mutant and wildtype popdc2 proteins displayed
aberrant membrane trafﬁcking (Schindler et al., 2016). The rather
mild limb-girdle muscular dystrophy phenotype present in the
family carrying the S201F mutation, which display a late onset, was
associated with ﬁbre size variability, central nuclei, and plasma
membrane discontinuities, which are often found in patients with
dysferlinopathies and related muscle disorders (Bansal et al., 2003;
Magri et al., 2012). However, membrane localisation of Dystrophin,
Dysferlin, and Caveolin-3, which all are PIPs (Table 2), was not
altered in the muscle of homozygous patients (Schindler et al.,
2016). The S201F mutation is rare and screening of an additional
104 patients with a similar phenotype displaying cardiac
arrhythmia and muscular dystrophy revealed no additional case of
a patient carrying a POPDC1 mutation (Schindler et al., 2016)
therefore further work is required to search for mutations of POPDC
genes in different patient cohorts with cardiac and skeletal muscle
disease. Recently POPDC1 has been associated with atrial ﬁbrilla-
tion (AF) using a bioinformatics approach but mutations have not
yet been identiﬁed in AF patients (Tan et al., 2013). POPDC1 muta-
tions have been implicated in the development of Tetralogy of Fallot
(Wu et al., 2013). It has been hypothesised that extracellular matrix
disorders may be involved, which, however, remains speculative as
neither animal models harbouring these mutations were produced
nor functional experiments were carried out (Wu et al., 2013). A
study has recently been published assessing the expression levelsTable 2
Popdc interaction partners.
Protein Evidence Reference
TREK-1 GST-PD, Co-IP, Co-IF, FRET, TEVC (Froese et al., 2012)
Caveolin-3 Co-IP, Co-IF (Alcalay et al., 2013)
Dystrophin Co-IP, Co-IF (Schindler et al., 2016)
Dysferlin Co-IP, Co-IF (Schindler et al., 2016)
VAMP2, VAMP3 Y2H, GST-PD, Co-IF (Hager et al., 2010)
GEFT Y2H, GST-PD, Co-IF (Smith et al., 2008)
NDRG4 Y2H, GST-PD, Co-IP, Co-IF (Benesh et al., 2013)
ZO1 GST-PD, Co-IF, IG-EM (Osler et al., 2005)
Abbreviations: Co-IF e co-localisation by immunoﬂuorescence, Co-IPT e co-
immunoprecipitation, FRETe ﬂuorescence resonance energy transfer, GST-PD e
Glutathione S-transferase pull down, IG-EM- Immunogold electron microscopy,
TEVC e two electrode voltage clamp, Y2H e Yeast two hybrid.of POPDC proteins in heart failure samples and a down-regulation
of POPDC1 and POPDC3 and to a lesser degree also of POPDC2 in
failing compared to normal control hearts has been reported
(Gingold-Belfer et al., 2011). In contrast, POPDC1 expression was
upregulated in patients with ventricular septal defects (Zhang et al.,
2006) suggesting complex regulation of POPDC protein expression
in different human cardiac diseases.
In addition to the cardiac phenotypes seen in Popdc null mutant
mice, zebraﬁsh morphants, and patients (see above) also skeletal
muscle physiology is affected. It has been reported that hindlimb
muscles (gastrocnemius and soleus) of Popdc1 null mutants have a
reduced regenerative capacity with a delay of muscle ﬁbre regen-
eration and maturation after injection of the snake venom car-
diotoxin, which causes muscle damage and subsequent
regeneration (Andree et al., 2002a). In zebraﬁsh, morpholino
oligonucleotide-mediated knockdown of popdc2 results in aberrant
tail morphology with abnormal formation of myotomal segment
boundaries, myoﬁbrillar misalignment and ruptured myoﬁbrils
(Kirchmaier et al., 2012). The level of disorganisation increased
with the age of the embryos. Interestingly, both fast and slow
muscle ﬁbres were affected by the knockdown but speciﬁcation of
ﬁbre types was not altered in popdc2 morphants. In addition,
myotendinous junctions were severely affected, myotomal borders
abnormally thin and disorganised, and proteins important for cell-
matrix adhesion like the Focal Adhesion Kinase (FAK) and vinculin
were expressed discontinuously in the junction region. In addition
to these impairments of the tail musculature, craniofacial muscles
were smaller and abnormally shaped (Kirchmaier et al., 2012). In
contrast to the developmental defects seen in zebraﬁsh morphants,
mouse null mutants do not show any embryonic phenotype, sug-
gesting that zebraﬁsh are much more sensitive to depletion of
Popdc protein expression. It will be important to study these
skeletal muscle phenotypes in both animal models in further detail
to unravel the underlying pathomechanisms. Although it has been
proposed that the muscular phenotype in the animal models re-
sults from the role of Popdc1 on cell motility and involves the
interaction with GEFT and Vamp2 and -3, which have been impli-
cated in muscle regeneration before (Hager and Bader, 2009; Hager
et al., 2010; Smith et al., 2008), other mechanisms are likely to be
involved as well, such as functions in the nuclear envelope where
Popdc proteins are also present (Korfali et al., 2012; Wilkie et al.,
2011).6. Summary and outlook
In the past 15 years, impressive progress has been made in
studying Popdc protein function, which nicely demonstrate the
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plethora of physiological processes in several organs and tissue
types. However, many aspects remain still unclear and deserve
further studies. These include for example the role of Popdc3, which
is the least studied member of the Popdc family. Moreover, it has
yet to be determined how the different Popdc family members are
functionally related, as the phenotypes that occur after depletion of
either Popdc1 or Popdc2 show signiﬁcant functional overlap indi-
cating some form of “crosstalk”. Given the high expression levels of
Popdc proteins in striated muscle and the complexity of the phe-
notypes in skeletal muscle and heart arising from inactivation and
mutation makes it necessary to study the underlying molecular
mechanisms in more detail and identify the protein networks that
are modulated by Popdc proteins in different muscle cell types. For
a better understanding of how Popdc proteins work and to deﬁne
their precise role, it will be mandatory to understand the role of
cAMP-binding for Popdc protein function and in particular its effect
on proteineprotein interaction and how this might have an impact
at the structural and functional level. It will also be important to
understand better how Popdc proteins are regulated, e.g. the role of
alternative splicing or posttranslational modiﬁcation such as
glycosylation, phosphorylation or proteolytic processing. This will
result in a better understanding of the various physiological and
pathophysiological processes Popdc proteins are associated with in
striated muscle tissue and beyond.
Editors' note
Please see also related communications in this issue by Schultz
et al. (2016) and Moghtadaei et al. (2016).
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